{"version":"1.0","type":"link","title":"SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial.","author_name":"Helgadottir H 외","author_url":"https://prs-insight.online/author/Helgadottir%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168239","thumbnail_width":1200,"thumbnail_height":630}